MGteam

Phase 3 trials for Descartes-08 are currently underway. This promising treatment showed significant results in earlier trials, with 80% of participants experiencing meaningful improvements in MG symptoms after just six weekly outpatient infusions.

The best first step is to discuss this treatment option with your Show Full Answer

Phase 3 trials for Descartes-08 are currently underway. This promising treatment showed significant results in earlier trials, with 80% of participants experiencing meaningful improvements in MG symptoms after just six weekly outpatient infusions.

The best first step is to discuss this treatment option with your neurologist. They can help determine if you might be eligible for the clinical trials and provide guidance on how to access them. Key points about Descartes-08:
• Does not require chemotherapy
• Administered as outpatient treatment
• Earlier trials showed minimal side effects
• Nearly 1 in 3 participants reached minimal to no symptoms
• Common side effects included fever, chills, headache, and nausea

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

80% See MG Symptom Relief in Early Cell Therapy Trial